Systemic Nalbuphine Versus Intravenous Regional Anesthesia

Assiut University

Status: Completed

Conditions: Postoperative Pain

Treatments: Drug: Local nalbuphine; Drug: Systemic nalbuphine

Study type: Interventional

Funder types: Other

Identifiers

NCT03150732

000087273

Details and patient eligibility

About

Comparison of systemic nalbuphine versus intravenous regional anesthesia in patients undergoing hand surgery.

Enrollment: 82 patients

Sex: All

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients scheduled for elective unilateral hand surgery.

Exclusion criteria

• Patient refusal.
• Allergy to study medications
• Body mass index > 35 kg/ m2
• Patients with sickle cell or Reynaud diseases
• Patients with a history of psychiatric illness or on chronic opioids

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

82 participants in 2 patient groups

Systemic nalbuphine group

Active Comparator group

Description:

53 patients will receive nalbuphine systemically

Treatment:

Drug: Systemic nalbuphine

Local nalbuphine group

Active Comparator group

Description:

53 patients will receive nalbuphine with local intravenous regional anesthesia (IVRA)

Treatment:

Drug: Local nalbuphine